Humanity might have finally discovered the right weapons to fight against deadly diseases as a new anti-HIV vaccine is being tested by scientists. According to the findings of three individual studies, the new vaccine could help the human immune system develop cells that neutralize the HIV strains.
Medical experts have been trying to figure out a solution to effectively combat HIV for decades. The best solution, in their opinion, is to strengthen the immune system and to enable it to fight against the vital disease.
Patients, who suffer from HIV have very weak immune systems and are therefore, prone to fall victims to many other diseases in addition to the HIV virus. For that matter, all the previous efforts that medical scientists have made were in relation to the immune system and the possible methods experts can use to stimulate antibody production.
World-renowned scientists working for the Scripps Research Institute, the Rockefeller University and the International AIDS Vaccine Initiative teamed up to carry out additional tests on lab rabbits and monkeys. They were particularly interested in the ability of the HIV strain to connect to cells and how these cells respond once the respondents have been injected with the new vaccine.
According to researchers, the vaccine allows the healthy cell to protect itself against the HIV strain. Nevertheless, additional tests were carried out to identify the precise stages that the vaccine gets through before it begins to stimulate antibody production.
To confirm or deny their second hypothesis experts at the said science institutions, administered the new vaccine to ill mice. They were, thus, able to see that the immune system must first be made vulnerable in the face of the HIV strain and then protected through a coax protein in order for the vaccine to be effective.
Much like in the case of many other vaccines, scientists have once again proven that the immune system has to be first sickened so antibodies would be produced. Once a sufficient number of antibodies was formed, the vaccine releases a new protein, which works as a protection against the HIV strain.
Further studies have shown that the immunization was determined by the eOD-GT8 60mer substance in the vaccine. Scientists are now keen on proving whether this substance is just as effective for the human body as it has been for the mice.
The recent medical findings will be published in the journals Cell and Science.
Image source: img.medicalxpress.com